Company / Capital Returned to Shareholders per Share
Royalty Pharma plc Capital Returned to Shareholders per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$2.04
FY2025
5-year range
$0.01 / $2.04
FY2021-FY2025
Trend
+288.3%
vs FY2024
Sector context
#16 of 51
Health Care
What the data says
Capital Returned to Shareholders per Share changed +288% YoY in FY2025, a notable deviation from the 3-year average annual change of +2209%.
Based on SEC 10-K filings.
2.04 in FY2025.
Improved from $0.73 to $2.04 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#16 of 51 in Health CareTop 31% of 51This company $2.04 Sector average $2.74
▼
-25.6% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 288.3% year-over-year.
- Ranks #16 out of 51 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.04 | +288.3% |
| FY2024 | $0.52 | -28.6% |
| FY2023 | $0.73 | - |
| FY2022 | - | - |
| FY2021 | $0.01 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026